Findings from the Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS) registry ...

The first FDA-approved automated tool that classifies and tracks cardiogenic shock provides patient data in real time, helping clinicians see information that’s often unrecognized and to quickly ...

The study questions whether it may be best to wait to implant a support device until arriving at a level 1 shock center.

About Supira Medical, Inc. Supira Medical is focused on the development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures and experiencing cardiogenic shock.

Numerous knowledge gaps exist regarding the care of female patients with cardiogenic shock, often because they have been consistently underrepresented in clinical trials, according to a new consensus ...

While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...

New clinical guidance to help cardiologists navigate the complexity of cardiogenic shock and assess possible cases within the first hour after onset introduces a memory aid — SUSPECT — which stands ...

Please provide your email address to receive an email when new articles are posted on . Risk for death was lower with the pump vs. standard care only, but incidence of adverse events was elevated. The ...

AMSTERDAM -- Venoarterial extracorporeal membrane oxygenation (VA ECMO) didn't improve survival with cardiogenic shock, the ECLS-SHOCK trial showed. This form of extracorporeal life support (ECLS) ...

New data from the CDC WONDER database finds deaths from heart attack-related cardiogenic shock (CS) decreased between 1999 ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...